Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia

Overview of attention for article published in Frontiers in oncology, May 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 4 news stories from 4 outlets.

Abstract Background Mixed lineage leukemia 1-rearranged (MLL1-r) acute leukemia patients respond poorly to currently available…

Akute myeloische Leukämie (AML) weist derzeit mit 29,5 % die niedrigste 5-Jahres-Überlebensrate aller Leukämien auf, verglichen…

Acute myeloid leukemia (AML) currently holds the lowest 5-year survival rate of all the leukemias at 29.5%, compared with 70.6…

In Partnership With: In acute myeloid leukemia, investigators are exploring novel agents engineered to target adhesion factors…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.